Junior Bravia Orally Disintegrating Tablet contains Lansoprazole 15mg, a proton pump inhibitor indicated for the treatment of acid-related gastrointestinal conditions in pediatric patients. Lansoprazole acts by selectively inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, thereby suppressing gastric acid secretion. This formulation is designed to disintegrate rapidly in the oral cavity without the need for water, facilitating ease of administration in children who may have difficulty swallowing conventional tablets. Junior Bravia is primarily used for the management of gastroesophageal reflux disease (GERD), erosive esophagitis, and other conditions associated with excessive stomach acid production. The onset of action typically occurs within one hour, providing symptomatic relief and promoting mucosal healing. Dosage should be individualized based on the severity of the condition and patient response, with careful consideration of age and weight. Common adverse effects may include headache, abdominal pain, diarrhea, and nausea, though these are generally mild and transient. Lansoprazole should be used with caution in patients with hepatic impairment and is contraindicated in those with known hypersensitivity to the drug or its components. Consultation with a healthcare professional is recommended prior to initiation to ensure appropriate use and monitoring.